Total Payments
$506.72
2024 Payments
$18.07
Companies
13
Transactions
34
Medicare Patients
1,512
Medicare Billing
$153,205
Payment Breakdown by Category
Food & Beverage$506.72 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $506.72 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $139.46 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $123.19 | 9 | $0 (2023) |
| Shire North American Group Inc | $44.47 | 3 | $0 (2018) |
| PFIZER INC. | $42.93 | 3 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $24.74 | 2 | $0 (2021) |
| Novo Nordisk Inc | $23.82 | 1 | $0 (2017) |
| Neos Therapeutics, LP | $17.25 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $16.69 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $15.80 | 1 | $0 (2017) |
| SANOFI PASTEUR INC. | $15.64 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.07 | 1 | AstraZeneca Pharmaceuticals LP ($18.07) |
| 2023 | $58.76 | 4 | Merck Sharp & Dohme LLC ($29.96) |
| 2022 | $50.22 | 3 | Merck Sharp & Dohme LLC ($20.03) |
| 2021 | $66.04 | 5 | AstraZeneca Pharmaceuticals LP ($29.37) |
| 2020 | $24.84 | 2 | AstraZeneca Pharmaceuticals LP ($12.96) |
| 2019 | $12.26 | 1 | Merck Sharp & Dohme Corporation ($12.26) |
| 2018 | $105.07 | 7 | Shire North American Group Inc ($44.47) |
| 2017 | $171.46 | 11 | AstraZeneca Pharmaceuticals LP ($44.83) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Respiratory | ||||||
| 08/17/2023 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: VACCINE | ||||||
| 04/27/2023 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: VACCINE | ||||||
| 04/20/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: VACCINES | ||||||
| 03/02/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Oncology | ||||||
| 10/13/2022 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Dermatology | ||||||
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), ROTATEQ, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: VACCINE | ||||||
| 09/23/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXELIS | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: VACCINE | ||||||
| 06/03/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/27/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: PRIMARY CARE | ||||||
| 02/25/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PRIMARY CARE | ||||||
| 02/09/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: VACCINE | ||||||
| 09/19/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: VACCINE | ||||||
| 09/27/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: ADHD | ||||||
| 09/13/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: VACCINE | ||||||
| 06/19/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2018 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: VACCINE | ||||||
| 12/05/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/30/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 314 | 424 | $69,376 | $35,615 |
| 2022 | 5 | 325 | 428 | $68,724 | $35,734 |
| 2021 | 6 | 408 | 535 | $85,228 | $46,757 |
| 2020 | 9 | 465 | 615 | $83,341 | $35,100 |
Total Patients
1,512
Total Services
2,002
Medicare Billing
$153,205
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 109 | 109 | $29,430 | $14,310 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 104 | $17,680 | $10,306 | 58.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 166 | $20,916 | $10,152 | 48.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $1,350 | $846.99 | 62.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $0.18 | $0.18 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 139 | $23,630 | $13,004 | 55.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $25,650 | $12,817 | 50.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 144 | $18,144 | $9,117 | 50.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,300 | $795.86 | 61.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $0.24 | $0.24 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 121 | 121 | $32,670 | $16,835 | 51.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 91 | 148 | $25,160 | $14,496 | 57.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 173 | $21,798 | $11,970 | 54.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 13 | 13 | $3,250 | $2,622 | 80.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 47 | 47 | $2,350 | $833.31 | 35.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 33 | 33 | $0.33 | $0.33 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 104 | 104 | $28,080 | $12,606 | 44.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 146 | $26,215 | $10,725 | 40.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 117 | 181 | $22,950 | $9,418 | 41.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 57 | 59 | $2,950 | $1,039 | 35.2% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 17 | 42 | $1,890 | $756.48 | 40.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 15 | 15 | $450.00 | $263.05 | 58.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 34 | 36 | $675.33 | $165.00 | 24.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 12 | 12 | $130.10 | $127.50 | 98.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 20 | 20 | $0.20 | $0.20 | 100.0% |
About Dr. James Stuart, DO
Dr. James Stuart, DO is a Internal Medicine healthcare provider based in Westerly, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053324384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Stuart, DO has received a total of $506.72 in payments from pharmaceutical and medical device companies, with $18.07 received in 2024. These payments were reported across 34 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($506.72).
As a Medicare-enrolled provider, Stuart has provided services to 1,512 Medicare beneficiaries, totaling 2,002 services with total Medicare billing of $153,205. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Westerly, RI
- Active Since 08/15/2006
- Last Updated 04/24/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053324384
Products in Payments
- FARXIGA (Drug) $121.39
- PNEUMOVAX 23 (Biological) $66.88
- VYVANSE (Drug) $44.47
- GARDASIL 9 (Biological) $31.96
- PREVNAR - 13 (Biological) $27.61
- NURTEC ODT (Drug) $24.74
- ZOSTAVAX (Biological) $24.35
- Levemir (Drug) $23.82
- BREZTRI (Drug) $18.07
- Adzenys XR-ODT (Drug) $17.25
- Myrbetriq (Drug) $16.69
- ADVAIR (Drug) $15.80
- MENACTRA (Drug) $15.64
- ALLODERM (Device) $15.48
- COMIRNATY (Biological) $15.32
- Xeomin (Biological) $13.77
- Cologuard Collection Kit (Device) $13.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Westerly
Vindhya Sriramoju, Md, MD
Internal Medicine — Payments: $2,644
Internal Medicine $2,644
Dr. Lisa Noyes-Duguay, M.d, M.D
Internal Medicine — Payments: $1,892
Internal Medicine $1,892
Dr. Sumaira Ali, M.d, M.D
Internal Medicine — Payments: $1,004
Internal Medicine $1,004
Peter Bolton, M.d, M.D
Internal Medicine — Payments: $475.69
Internal Medicine $475.69
Ahmed Elshazly, Md, MD
Internal Medicine — Payments: $456.42
Internal Medicine $456.42
Paula Watts-Wojcik, Do, DO
Internal Medicine — Payments: $303.44
Internal Medicine $303.44